DURHAM, N.C.--(BUSINESS WIRE)--Trimeris, Inc. (Nasdaq: TRMS) today announced worldwide net sales of FUZEON for the third quarter of 2009 were $29.8 million, down 35 percent from $45.5 million in the third quarter of 2008, and up 2 percent from $29.1 million in the second quarter of 2009. Net sales of FUZEON in the U.S. and Canada for the third quarter of 2009 were $10.4 million, down 31 percent from $14.9 million in the third quarter of 2008, and up 7 percent from $9.7 million in the second quarter of 2009. Net sales of FUZEON outside the U.S. and Canada for the third quarter of 2009 were $19.4 million, down 37 percent from $30.6 million in the third quarter of 2008, and showed no change from $19.4 million in the second quarter of 2009. All sales of FUZEON are recorded by F. Hoffmann-La Roche Ltd. ("Roche"), Trimeris' collaborative partner.
